Victory Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.8M | Buy |
|
|||||
|
2025
Q1 | $19.5M | Sell |
|
|||||
|
2024
Q4 | $18.1M | Sell |
|
|||||
|
2024
Q3 | $20M | Sell |
|
|||||
|
2024
Q2 | $18.3M | Sell |
|
|||||
|
2024
Q1 | $20.3M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $66.8M | Buy |
|
|||||
|
2020
Q4 | $84.7M | Buy |
|
|||||
|
2020
Q3 | $56.4M | Sell |
|
|||||
|
2020
Q2 | $58.9M | Sell |
|
|||||
|
2020
Q1 | $90.4M | Buy |
|
|||||
|
2019
Q4 | $75.8M | Buy |
|
|||||
|
2019
Q3 | $42.2M | Buy |
|
|||||
|
2019
Q2 | $39.3M | Buy |
|
|||||
|
2019
Q1 | $38M | Buy |
|
|||||
|
2018
Q4 | $1.46M | Sell |
|
|||||
|
2018
Q3 | $1.68M | Sell |
|
|||||
|
2018
Q2 | $1.66M | Sell |
|
|||||
|
2018
Q1 | $1.72M | Buy |
|
|||||
|
2017
Q4 | $696K | Buy |
|
|||||
|
2017
Q3 | $194K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $144K | Buy |
|